News | May 04, 2010

FDG-PET Distinguishes Acute, Chronic Aortic Dissection

Aortic dissection (AD).


May 4, 2010 - Currently, using conventional imaging modalities to distinguish between acute and chronic aortic dissection (AD) for surgical risk evaluation is not possible. However, in a recent study, researchers were able to use fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) to detect reparatory hypermetabolism in the lacerated aortic wall of acute AD. This allowed them to determine if patients had acute or chronic stable AD.

Investigators at the Clinic for Vascular Surgery in Munich, Germany, analyzed the 18F-FDG uptake in the aortic wall of acute and chronic stable AD in 18 patients. Researchers analyzed the images qualitatively and looked at 18F-FDG uptake patterns and the standardized uptake values (SUVs) of the aortic wall, dissection membrane, and luminal 18F-FDG activity. The standard uptake value (SUV) ratio (maximum SUV in the aorta divided by mean SUV in the blood pool) was calculated to relativize individual luminal 18F-FDG spillover effects.

In contrast to chronic stable AD, all acute or acute progressive AD showed accentuated 18F-FDG uptake at the injured aortic wall or dissection membrane. The maximum SUV of the dissection membrane or aortic wall was significantly higher in acute AD than in chronic stable AD. Thereby, SUV varied from 3.03 to 4.64 (average maximum SUV, 3.84 ± 0.51) for the dissection membrane and from 2.22 to 4.60 (average maximum SUV, 2.94 ± 0.81) for the aortic wall, with false-negative and false-positive outliers. The discrimination between acute and stable AD was improved significantly, and false-positive or negative outliers were eliminated, using the SUV ratio method.

The results indicated 18F-FDG PET/CT might be useful in differentiating acute from chronic AD in clinically unclear cases. Researchers cautioned that larger studies are needed to confirm our preliminary results.

Reference: Reeps, C., Pelisek, J., Bundschuh, R., et al. "Imaging of Acute and Chronic Aortic Dissection by 18F-FDG PET/CT." The Journal of Nuclear Medicine. May, 1 2010; Vol. 51, No. 5

For more information: jnm.snmjournals.org


Related Content

News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Home July 25, 2024
Home
News | PET-CT

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Home July 11, 2022
Home
News | PET-CT

July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the ...

Home July 13, 2021
Home
Feature | PET-CT | Dave Fornell, Editor

As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if ...

Home February 19, 2020
Home
Videos | PET-CT

Rupa Sanghani, M.D., FASNC, associate professor, Rush Medical College, director of nuclear cardiology and stress ...

Home October 30, 2019
Home
News | PET-CT

March 5, 2019 — Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) ...

Home March 06, 2019
Home
Technology | PET-CT

September 26, 2018 — Bruker recently announced the introduction of the new preclinical PET/CT Si78 scanner for whole ...

Home September 26, 2018
Home
Technology | PET-CT

June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system ...

Home June 21, 2018
Home
Technology | PET-CT

June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission ...

Home June 05, 2018
Home
News | PET-CT

July 25, 2017 — Using a new nuclear imaging technique that can diagnose cardiac sarcoidosis much more accurately than ...

Home July 25, 2017
Home
Subscribe Now